Skip to content
Catalyst

knowcompoundspyridoxine

Specimen compound organic compoundPlate I

Pyridoxine

Nested hairline contours trace the electron density of one computed shape of pyridoxine, teal at the edge warming to amber over the atoms.
fig. 1Pyridoxine · electron density · PubChem CID 1054, computed 3D conformer
Formula
C8H11NO3
Molar mass
169.18 g/mol
PubChem CID
1054
InChIKey
LXNHXLLTXMVWPM-UHFFFAOYSA-N

↓ lowered 8 findings in 6 endpoints · – no difference found 7 in 5

01 · the evidence, ordered

What the evidence says

Strong
0
Moderate
0
Limited
0
Very limited
13
Insufficient
2

How to read these marks

Fig. 2 Pyridoxine CHEBI:16709 9 endpoints 15 findings
×1.60
Labels
CompoundInspector

Pyridoxine

Most findings

  • Colorectal cancer incidence×5
  • Breast cancer incidence×3
  • All-site cancer incidence×1
  • Beck Depression Inventory (BDI) total score×1
Show the remaining 5Show the first 4
  • Incidence of coronary heart disease×1
  • Incidence of stroke×1
  • Pancreatic cancer incidence×1
  • Parkinson's disease incidence×1
  • Pre-eclampsia incidence×1

18 reference statements, not drawn · 36 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

  1. Colorectal cancer incidencecontested
  2. Breast cancer incidencecontested
  3. All-site cancer incidence
  4. Beck Depression Inventory (BDI) total score
  5. Incidence of coronary heart disease
  6. Incidence of stroke
  7. Pancreatic cancer incidence
  8. Parkinson's disease incidence
  9. Pre-eclampsia incidence
Show the remaining 1Show the first 8
fig. 3 · 9 endpoints · 15 findingscontested · an endpoint whose findings disagree

02 · contested · 2 endpoints

Where the findings disagree

  1. 015 findings

    Colorectal cancer incidence

    ↓ lowered
    3
    – no difference found
    2
  2. 023 findings

    Breast cancer incidence

    ↓ lowered
    1
    – no difference found
    2

03 · findings

What pyridoxine moved, and by how much

  • HR hazard ratio · RR risk ratio. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
Direction
Strength, at least

12 of 15 shown

  1. Parkinson's disease incidenceMoved: lowersEffect, as reportedHR0.69[0.5 to 0.96]Evidence: Very limitedPaper: PMID 168648262006
    Who
    Community-dwelling adults aged 55 years and older, free of dementia and parkinsonism at baseline (Rotterdam Study); dietary intake by food frequency assessment
    Dose studied
    dietary vitamin B6 intake, per SD

    Higher dietary intake of vitamin B6 was associated with a significantly decreased risk of PD (hazard ratio per SD, 0.69 [95% CI 0.50 to 0.96]; for highest vs lowest tertile, 0.46 [0.22 to 0.96]).”

    Quoted verbatim from Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.cohortPermalink
  2. Beck Depression Inventory (BDI) total scoreMoved: lowersEvidence: Very limitedPaper: PMID 351097632023
    Who
    Healthy college women aged 18-25 using oral contraceptives, randomised double-blind crossover
    Dose studied
    100 mg vitamin B6 daily versus placebo, 4-week periods separated by a 4-week washout

    BDI-II scores were reduced 20% by vitamin B6 supplementation in comparison to an 11% rise with placebo ingestion (p = 0.046).”

    Quoted verbatim from Vitamin B6 Supplementation Reduces Symptoms of Depression in College Women Taking Oral Contraceptives: A Randomized, Double-Blind Crossover Trial.crossover · 4 weeksPermalink
  3. Incidence of strokeMoved: no difference foundEvidence: Very limitedPaper: PMID 182703692008
    Who
    Male Finnish smokers aged 50-69 years in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; dietary vitamin B6 intake by food frequency questionnaire
    Dose studied
    not reported

    Vitamin B(6), vitamin B(12), and methionine intakes were not significantly associated with any subtype of stroke.”

    Quoted verbatim from Folate, vitamin B6, vitamin B12, and methionine intakes and risk of stroke subtypes in male smokers.cohortPermalink
  4. Colorectal cancer incidencecontestedMoved: no difference foundEvidence: Very limitedreplicated ×1Paper: PMID 163390552006
    Who
    US women aged 45 years or older, free of cancer and cardiovascular disease at baseline, enrolled in a randomized aspirin and vitamin E trial; total vitamin B6 intake from diet plus supplements, highest versus lowest quintile
    Dose studied
    not reported

    Total folate and vitamin B(6) intakes were not significantly associated with the risk of colorectal cancer.”

    Quoted verbatim from Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women.cohortPermalink
  5. Incidence of coronary heart diseaseMoved: lowersEvidence: Very limitedPaper: PMID 304313282019
    Who
    General population, eleven prospective cohort studies; dietary intake gradient
    Dose studied
    not reported

    In conclusion, higher intake of folate and vitamin B6 is associated with a lower risk of CHD in the general population.”

    Quoted verbatim from Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies.meta-analysisPermalink
  6. Colorectal cancer incidencecontestedMoved: lowersEvidence: Very limitedreplicated ×2Paper: PMID 193365552009
    Who
    Men in the Physicians' Health Study; nested case-control (197 incident colorectal cancer cases, 371 matched controls), prediagnostic plasma PLP by quartile
    Dose studied
    not reported

    Plasma PLP levels were inversely associated with colorectal cancer risk; a lower risk of colorectal cancer was observed mainly among participants in the two higher quartiles.”

    Quoted verbatim from Prospective study of plasma vitamin B6 and risk of colorectal cancer in men.case-controlPermalink
  7. Pre-eclampsia incidenceMoved: no difference foundEvidence: Very limitedPaper: PMID 166255302006
    Who
    Pregnant women; oral vitamin B6 as capsules or lozenges versus non-supplemented groups
    Dose studied
    not reported

    We did not find any statistically significant differences in the risk of eclampsia (capsules: n = 1242; three trials; lozenges: n = 944; one trial), pre-eclampsia (capsules n = 1197; two trials; lozenges: n = 944; one trial) or low Apgar scores at one minute (oral pyridoxine: n = 45; one trial), between supplemented and non-supplemented groups.”

    Quoted verbatim from Pyridoxine (vitamin B6) supplementation in pregnancy.meta-analysisPermalink
  8. All-site cancer incidenceMoved: lowersEffect, as reportedRR0.78[0.73 to 0.84]Evidence: Very limitedPaper: PMID 283762002017
    Who
    Observational studies; highest versus lowest dietary (food only) vitamin B6 intake; total intake (food and supplements) gave weaker or null associations
    Dose studied
    not reported

    High intake of dietary (food only) vitamin B6 was statistically significantly associated with lower risk of all cancers (relative risk [RR] = 0.78, 95% CI = 0.73 to 0.84) and specific tumors, with special regard to gastrointestinal carcinomas (RR = 0.68, 95% CI = 0.61 to 0.75).”

    Quoted verbatim from Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis.meta-analysisPermalink
  9. Breast cancer incidencecontestedMoved: no difference foundEvidence: Very limitedreplicated ×1Paper: PMID 193892612009
    Who
    Brazilian women in a hospital-based case-control study (458 age-matched pairs), energy-adjusted dietary intake by tertile, all women
    Dose studied
    not reported

    Using the lowest tertile intake of folate, vitamin B6, and vitamin B12 as reference, no statistically significant association was observed between vitamin intake and breast cancer risk in all women (Table 2).”

    Quoted verbatim from Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women.case-controlPermalink
  10. Pancreatic cancer incidenceMoved: no difference foundEvidence: Very limitedPaper: PMID 172418652007
    Who
    Swedish women and men aged 45-83 years free from cancer at baseline, prospective population-based cohort; dietary or total vitamin B6 intake by food-frequency questionnaire
    Dose studied
    not reported

    Methionine intake was significantly inversely associated with risk of pancreatic cancer, whereas no significant association was observed for dietary or total vitamin B(6) intake.”

    Quoted verbatim from Methionine and vitamin B6 intake and risk of pancreatic cancer: a prospective study of Swedish women and men.cohortPermalink
  11. Breast cancer incidencecontestedMoved: no difference foundEvidence: Very limitedreplicated ×1Paper: PMID 198389162009
    Who
    Japanese women: hospital-based case-control study of patients with invasive breast cancer and age- and area-matched controls from medical checkup examinees; dietary intake by food frequency questionnaire
    Dose studied
    not reported

    Neither dietary intake of folate, vitamin B2, vitamin B6, or vitamin B12 nor polymorphisms of MTHFR or MTR genes were significantly associated with breast cancer risk.”

    Quoted verbatim from Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan.case-controlPermalink
  12. Colorectal cancer incidencecontestedMoved: lowersEvidence: Very limitedreplicated ×2Paper: PMID 159406182005
    Who
    Women aged 40 to 76 years without prior cancer in the Swedish Mammography Cohort; dietary vitamin B6 intake by food-frequency questionnaire
    Dose studied
    long-term dietary vitamin B6 intake, quintiles

    After controlling for age and other potential confounders, long-term intake of dietary vitamin B6 was significantly inversely associated with risk of colorectal cancer (P value for trend = .002).”

    Quoted verbatim from Vitamin B6 intake, alcohol consumption, and colorectal cancer: a longitudinal population-based cohort of women.cohortPermalink

No dose is advised.

  • HR hazard ratio · RR risk ratio. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

04 · identity

Structure

fig. 4Pyridoxine · 2D structure · ChEBI’s SMILES
Charge
0
SMILES
Cc1ncc(CO)c(CO)c1O

05 · figures · 1 plate

Plates

  • A dial of hairlines, each a peak of pyridoxine's measured mass spectrum, its angle the peak's mass-to-charge ratio and its length the peak's intensity.
    fig. 5Pyridoxine · MS2 [M+H]+ LC-ESI-QFT positive · MassBank MSBNK-ACES_SU-AS000477 (ACESx, CC BY)

06 · reach

What it touches on the way

4 entities · assembled from reference reactions

  1. PDXKProtein24 paths · 12 endpointsinferred
  2. PNPOProtein7 paths · 7 endpointsinferred
  3. SLC19A3Protein2 paths · 2 endpointsinferred
  4. SLC19A2Protein1 path · 1 endpointinferred

07 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
1801 Compoundpyridoxal, pyridoxine 5'-phosphate02 ProteinSLC19A2, SLC19A3, SLC49A4, PDXK, PNPOinferred, one hop from pyridoxine
Reactions · Rhea
14reactions
18Reference statements

What the reference databases state

Evidence key

Chemical structure

Statements

18 statements

2 of 3 reference databases · Sources: Human-GEM, Rhea

1233pyridoxine18 STATEMENTS
14Reactions

08 · on the label · 11,710 products

Labelled products

Source: NIH DSLD · Ingredient: pyridoxine · 11,710 products · Declared amount per serving (the first 1,000 shown): 0.001–180 mg

972 labels of the first 1,000 shown state an amount28 do not

  • 1st PhormM-Factor HeroVitamin B6, Pyridoxine Hydrochloride, as pyridoxine hcl50 mgper 3 capsulesDSLD:12881
  • 21st CenturyDiabetic Support FormulaVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl3 mgper 3 tabletsDSLD:11189
  • 21st CenturyOne Daily ActiveVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl6 mgper 1 tabletDSLD:11548
  • 21st CenturyOne Daily Adults 50+Vitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl6 mgper 1 tabletDSLD:11549
  • 21st CenturyOne Daily Cholesterol Health With PolicosanolVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl2 mgper 1 tabletDSLD:11550
  • 21st CenturyOne Daily EnergyVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl4 mgper 1 tabletDSLD:11552
  • 21st CenturyOne Daily EssentialVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl2 mgper 1 tabletDSLD:11556
  • 21st CenturyOne Daily MaximumVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl2 mgper 1 tabletDSLD:11558
  • 21st CenturyOne Daily Men's HealthVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl3 mgper 1 tabletDSLD:11559
  • 21st CenturyOne Daily Weight ControlVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl2.5 mgper 1 tabletDSLD:11560
  • 21st CenturyOne Daily Women'sVitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl2 mgper 1 tabletDSLD:11561
  • 21st CenturyOne Daily Women's 50+Vitamin B6, Pyridoxine Hydrochloride, as Pyridoxine HCl6 mgper 1 tabletDSLD:11497
Show the remaining 11,698Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

09 · the record

Sources

586

papers screened for pyridoxine

admitted
17
read and discarded
424
not read yet
145

The screening record, every paper and why